Anticoagulant Market Analysis By Drug Class (Factor XA Inhibitors (NOAC/DOAC), Heparins, Direct Thrombin Inhibitors, Vitamin K Antagonists), By Route of Administration (Oral, Injectable), By Indication (Deep Vein Thrombosis, Pulmonary Embolism, Atrial Fibrillation & Heart Attack, Ischemic Stroke, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
Report Overview The Global Anticoagulant Market size is expected to be worth around USD 66.1 Billion by 2033, from USD 34.9 Billion in 2023, growing at a CAGR of 6.6% during the fore...
